Sains Malaysiana 50(5)(2021):
1425-1431
http://doi.org/10.17576/jsm-2021-5005-21
Ascites in a Patient with Hairy Cell Leukaemia and Carcinoma of Breast: A Diagnostic Challenge
(Asites pada Pesakit Leukaemia Sel Berbulu
dan Karsinoma Payudara: Suatu Cabaran Diagnosis)
WINT WINT THU NYUNT1, AZIAN NAILA BINTI MD NOR2,
NORALISA ABDUL KARIM1, TANG YEE LOONG2, S FADILAH S ABDUL WAHID1*
& NOR RAFEAH TUMIAN3
1Pusat Terapi Sel, Faculty of
Medicine, Hospital Canselor Tuanku Muhriz UKM, 56000 Kuala Lumpur, Federal
Territory, Malaysia
2Department of Pathology, Faculty of
Medicine, Hospital Canselor Tuanku Muhriz UKM, 56000 Kuala Lumpur, Federal
Territory, Malaysia
3Department of Medicine, Faculty of
Medicine, Hospital Canselor Tuanku Muhriz UKM, 56000 Kuala Lumpur, Federal
Territory, Malaysia
Received:
3 January 2020/Accepted: 30 September 2020
ABSTRACT
Hairy
cell leukaemia (HCL) is a rare indolent B-cell lymphoproliferative disorder. We
report a diagnostic challenge in detecting the cause of ascites, which is a
rare, unique manifestation of HCL. A 72-year-old lady presented with
1-month-history of pain in left upper abdomen and loss of weight. There was
hepatomegaly, splenomegaly, bilateral inguinal lymphadenopathy, anaemia, and
lymphocytosis. She was diagnosed as HCL, based on morphology, immunophenotyping
of peripheral blood and bone marrow biopsy examination. In 2009, she was
diagnosed as carcinoma of breast when she presented with a mass in left breast;
and she received treatment. For HCL, she received intermittent chemotherapy
(Chlorambucil+Prednisolone). Her HCL was stable until 2018 when she presented
with recurrent ascites which needed frequent, regular peritoneal paracentesis.
Since she had HCL and carcinoma of breast, determining the aetiology of ascites
was challenging. Possible causes of her ascites included metastatic carcinoma
of breast, HCL, cirrhosis of liver with portal hypertension and peritoneal
tuberculosis. Cytology of peritoneal fluid showed mature-looking lymphocytes
but no malignant cells. Interestingly, flow cytometry analysis of peritoneal
fluid showed the presence of clonal B cell population with lambda light chain
restriction. Therefore, it was concluded that her ascites was a manifestation
of HCL. A few months later, she succumbed to septicaemia. Impact of ascites on
disease course of HCL included rapid disease progression, poor prognosis and
shortened survival. We highlight the important role of immunophenotyping in
addition to cytomorphology to guide us in confirming the aetiology of ascites
in a patient with haematological and solid organ malignancies.
Keywords:
Ascites; flow cytometry; hairy cell leukaemia; immunophenotyping
ABSTRAK
Leukaemia
sel berbulu (HCL) merupakan penyakit limfoproliferatif sel-B indolen yang
jarang berlaku. Kami melaporkan cabaran diagnosis dalam mengesan penyebab
asites, iaitu manifestasi HCL yang luar biasa dan unik. Seorang wanita berumur
72 tahun menunjukkan sejarah kesakitan di bahagian kiri atas abdomen selama
sebulan dan penurunan berat badan. Terdapat hepatomegali, splenomegali,
limfadenopati inguinal bilateral, anaemia dan limfositosis. Beliau didiagnos
sebagai HCL berdasarkan morfologi, imunofenotip darah periferi dan pemeriksaan
biopsi sumsum tulang. Pada tahun 2009, beliau didiagnos pula dengan karsinoma
payudara apabila terdapat gumpalan pada payudara kiri dan beliau telah menerima
rawatan. Bagi HCL, beliau menerima kemoterapi bersela
(Chlorambucil+Prednisolone). Penyakit HCL beliau stabil sehingga tahun 2018
apabila beliau mengalami asites berulang dan memerlukan parasentesis peritoneum
yang kerap. Oleh kerana beliau menghidap HCL dan karsinoma payudara, penentuan
etiologi asites tersebut menjadi amat mencabar. Beberapa kemungkinan punca
asitesnya termasuklah metastasis karsinoma payudara, HCL, sirosis hati dengan
hipertensi portal dan tuberkulosis peritoneum. Ujian sitologi cecair peritoneum
menunjukkan limfosit yang kelihatan matang namun tiada sel malignan.
Menariknya, analisis sitometri aliran cecair peritoneum menunjukkan kehadiran
populasi sel B klonal dengan sekatan rantai ringan lambda. Oleh itu,
disimpulkan bahawa asites tersebut merupakan manifestasi HCL. Beberapa bulan
kemudian, beliau meninggal dunia akibat septisemia. Kesan asites pada penyakit
HCL termasuklah perkembangan penyakit yang pantas, prognosis yang buruk dan
kelangsungan hidup yang pendek. Kami menekankan kepentingan imunofenotip selain
sitomorfologi dalam membimbing kami untuk mengesahkan etiologi asites pada
pesakit haematologi dan kemaglinanan organ pejal.
Kata
kunci: Asites; imunofenotip; leukaemia sel berbulu; sitometri aliran
REFERENCES
Arora, N., Mishra, A., Santra, P. & Nair, R. 2015. Hairy cell
leukaemia with ascites and coexistent histoplasmosis. Indian Journal of Pathology and Microbiology 58(1): 125-126.
Au, W.Y., Klasa, R.J., Gallagher, R., Le, N.,
Gascoyne, R.D. & Connors, J.M. 1998. Second malignancies in patients with
hairy cell leukaemia in British Columbia: A 20-year experience. Blood 92(4): 1160-1164.
Bouroncle, B.A. 1987. Unusual presentations and complications
of hairy cell leukaemia. Leukaemia 1(4):
288-293.
Cesana, C., Klersy, C., Scarpati, B., Brando,
B., Volpato, E., Bertani, G., Faleri, M., Nosari, A., Cantoni, S., Ferri, U.
& Scampini, L. 2010. Flow cytometry vs cytomorphology for the detection of
haematologic malignancy in body cavity fluids. Leukaemia Research 34(8): 1027-1034.
Cornet, E., Tomowiak, C., Tanguy‐Schmidt,
A., Lepretre, S., Dupuis, J., Feugier, P., Devidas, A., Mariette, C., Leblond,
V., Thiéblemont, C. & Validire‐Charpy, P. 2014. Long‐term
follow‐ up and second malignancies in 487 patients with hairy cell
leukaemia. British Journal of Haematology 166(3): 390-400.
Davies, G.E. & Wiernik, P.H. 1977. Hairy
cell leukaemia with chylous ascites. JAMA 238(14): 1541-1542.
Dinçol, G., Dogan, Ö., Küçükkaya, R.D., Gül, E.,
Kahraman, R. & Agan, M. 2008. Hairy cell leukaemia presenting with ascites,
pleural effusion and increased CA 125 serum level. The Netherlands Journal of Medicine 66(1): 23-26.
Grever, M.R., Abdel-Wahab, O., Andritsos, L.A.,
Banerji, V., Barrientos, J., Blachly, J.S., Call, T.G., Catovsky, D., Dearden,
C., Demeter, J., Else, M., Forconi, F., Gozzetti, A., Ho, A.D., Johnston, J.B.,
Jones, J., Juliusson, G., Kraut, E., Kreitman, R.J., Larratt, L., Lauria, F.,
Lozanski, G., Montserrat, E., Parikh, S.A., Park, J.H., Polliack, A., Quest,
G.R., Rai, K.R., Ravandi, F., Robak, T., Saven, A., Seymour, J.F., Tadmor, T.,
Tallman, M.S., Tam, C., Tiacci, E., Troussard, X., Zent, C.S., Zenz, T.,
Zinzani, P.L. & Falini, B. 2017. Consensus guidelines for the diagnosis and
management of patients with classic hairy cell leukaemia. Blood 129(5): 553-560.
Kayal, S., Radhakrishnan, V., Singh, S., Chopra,
A., Kumar, R. & Raina, V. 2011. Hairy cell leukaemia with ascites: An
unusual presentation. Leukaemia &
Lymphoma 52(3): 539-540.
Maitre, E., Cornet, E. & Troussard, X. 2019.
Hairy cell leukaemia: 2020 update on diagnosis, risk stratification, and
treatment. American Journal of Hematology 94(12): 1413-1422.
Morton, L.M., Wang, S.S., Devesa, S.S., Hartge,
P., Weisenburger, D.D. & Linet, M.S. 2006. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 107(1): 265-276.
Saven, A., Burian, C., Koziol, J.A. & Piro,
L.D. 1998. Long-term follow-up of patients with hairy cell leukaemia after
cladribine treatment. Blood 92(6):
1918-1926.
Shackelford, R.E., Heldmann, M., Eskandari, F.,
Joshi, N., Browning, J., Maxwell, N. & Coteligam, J. 2013. Marked
retroperitoneal lymphadenopathy in hairy cell leukaemia: A case report. Case Reports in Oncology 6(3): 493-496.
Tong, L.C., Ko, H.M., Saieg, M.A., Boerner, S.,
Geddie, W.R. & da Cunha Santos, G. 2013. Subclassification of
lymphoproliferative disorders in serous effusions: A 10‐year experience. Cancer Cytopathology 121(5): 261-270.
Weissman, G.S., McKinley, M.J., Budman, D.R.,
Caccese, W.J., Schulman, P., Grueneberg, D. & Bronzo, R.L. 1987. Flow
cytometry. A new technique in the diagnosis of malignant ascites. Journal of Clinical Gastroenterology 9(5):
599-602.
*Corresponding
author; email: sfadilah@ppukm.ukm.edu.my
|